Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M476Revenue $M33.9Net Margin (%)-59.8Z-Score-1.5
Enterprise Value $M376EPS $-0.7Operating Margin %-60.2F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-59.8Higher ROA y-yN
Price/Book22.810-y EBITDA Growth Rate %0Quick Ratio2.3Cash flow > EarningsN
Price/Sales12.75-y EBITDA Growth Rate %0Current Ratio2.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-14.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-45.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.9ROI % (ttm)-150.9Gross Margin Increase y-yY

Gurus Latest Trades with VNDA

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VNDAJohn Paulson 2014-03-31 Buy 0.11%$10.5 - $18.71
($14.13)
$ 14.060%New holding, 1392500 sh.1,392,500
VNDAJean-Marie Eveillard 2013-09-30 Sold Out -0.02%$8.05 - $13.031
($10.72)
$ 14.0631%Sold Out0
VNDAJean-Marie Eveillard 2013-06-30 Reduce-0.01%$3.93 - $13
($6.73)
$ 14.06109%Reduce -48.99%975,000
VNDAJean-Marie Eveillard 2012-12-31 Add0.01%$3.03 - $4.16
($3.54)
$ 14.06297%Add 43.16%1,911,452
VNDAJean-Marie Eveillard 2010-03-31 Add0.04%$10.01 - $12.38
($10.94)
$ 14.0628%Add 111.12%752,375
VNDAJean-Marie Eveillard 2009-12-31 Buy 0.04%$9.59 - $11.84
($10.79)
$ 14.0630%New holding, 356375 sh.356,375
VNDAJean-Marie Eveillard 2008-12-31 Add$0.53 - $0.87
($0.7)
$ 14.061909%Add 39.68%123,200
VNDAJean-Marie Eveillard 2008-03-31 Add$2.9 - $5.76
($4.5)
$ 14.06212%Add 162.5%105,000
VNDAJean-Marie Eveillard 2007-12-31 Add$6.79 - $17.41
($10.4)
$ 14.0635%Add 60%40,000
VNDAJean-Marie Eveillard 2007-09-30 Reduce$13.91 - $21.2
($16.6)
$ 14.06-15%Reduce -50%25,000
VNDAJean-Marie Eveillard 2007-06-30 Buy 0.01%$19.42 - $22.44
($20.9)
$ 14.06-33%New holding, 50000 sh.50,000
VNDAGeorge Soros 2006-12-31 Sold Out -0.24%$9.7 - $25.53
($16.3)
$ 14.06-14%Sold Out0
VNDAGeorge Soros 2006-06-30 Buy 0.33%$7.99 - $11
($9.5)
$ 14.0648%New holding, 268495 sh.268,495
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VNDA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VNDA John Paulson 2014-03-311,392,5004.110.11New Buy
Premium Most recent portfolio changes are included for Premium Members only!


VNDA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Watkins ThomasDirector 2014-03-14Sell35,000$17.66-20.39view
Repella RobertSVP & Chief Commercial Officer 2013-11-21Sell107,500$12.0316.87view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2013-11-19Sell3,348$12.0716.49view
Polymeropoulos Mihael HristosPresident and CEO 2013-11-19Sell8,928$12.0716.49view
Polymeropoulos Mihael HristosPresident and CEO 2012-02-16Sell11,350$4.69199.79view
Feeney John JosephSVP & Chief Medical Officer 2012-02-16Sell4,760$4.65202.37view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2012-02-16Sell4,920$4.67201.07view
Feeney John JosephSVP & Chief Medical Officer 2012-02-16Sell4,760$4.65202.37view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2011-08-29Buy5,000$5.99134.72view
Polymeropoulos Mihael HristosPresident and CEO 2011-08-23Buy10,000$5.35162.8view

Press Releases about VNDA :

    Quarterly/Annual Reports about VNDA:

      News about VNDA:

      Articles On GuruFocus.com
      John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
      Best Performing Gurus of Past Six Months are John Paulson, First Eagle and Michael Price Jun 11 2013 
      comment on VNDA Nov 12 2012 
      Vanda: This Company Has Great Assets But No Profits Jan 21 2012 
      Vanda Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
      $VNDA New study started: Oct 15 2010 
      Hourly trend UP Aug 11 2010 
      Vanda Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
      upgraded to BUY Jul 07 2010 
      Vanda Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 

      More From Other Websites
      Nasdaq stocks posting largest percentage increases Jul 23 2014
      Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 Jul 17 2014
      Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 Jul 17 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events Jul 17 2014
      3 Small-Cap Biotechs That Institutions Are Loving Jul 07 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events Jun 16 2014
      Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock Jun 11 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events Jun 10 2014
      [video] Small cap weekly winners Jun 06 2014
      Vanda Up on EU News Jun 05 2014
      Vanda Shares Jumped 29% Amid Continued Success Of Hetlioz Jun 05 2014
      Why Vanda Pharmaceuticals (VNDA) Stock Is Surging Today Jun 04 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 04 2014
      VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 03 2014
      European Medicines Agency Accepts HETLIOZ™ (tasimelteon) Marketing Authorization Application for... Jun 03 2014
      HETLIOZ™ (tasimelteon) Data in Patients with Non-24-Hour Sleep-Wake Disorder to be presented at... Jun 02 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide